For citations:
Mashin V.V., Sergeev A.N., Martynova N.N., Antipina T.V., Sakanyan E.I., Kataeva V.V., Zagidullin N.V. Minimisation of the viral contamination risk of heterologous immunoglobulins in the context of the requirements of the State Pharmacopoeia of the Russian Federation. Biological Products. Prevention, Diagnosis, Treatment. 2022;22(2):112-123. (In Russ.) https://doi.org/10.30895/2221-996X-2022-22-2-112-123
Email this article 